1. |
Williamson PR, Altman DG, Blazeby JM, et al. Developing core outcome sets for clinical trials: issues to consider. Trials, 2012, 13: 132.
|
2. |
Zhang L, Zhang J, Chen J, et al. Clinical research of traditional Chinese medicine needs to develop its own system of core outcome sets. Evid Based Complement Alternat Med, 2013, 2013: 202703.
|
3. |
Kirkham JJ, Davis K, Altman DG, et al. Core Outcome Set-STAndards for development: the COS-STAD recommendations. PLoS Med, 2017, 14(11): e1002447.
|
4. |
Moher D, Schulz KF, Simera I, et al. Guidance for developers of health research reporting guidelines. PLoS Med, 2010, 7(2): e1000217.
|
5. |
Kirkham JJ, Gorst S, Altman DG, et al. Core outcome set-standards for reporting: the COS-STAR statement. PLoS Med, 2016, 13(10): e1002148.
|
6. |
Kirkham JJ, Gorst S, Altman DG, et al. Core outcome set-standardised protocol items: the COS-STAP statement. Trials, 2019, 20(1): 116.
|
7. |
邱瑞瑾, 胡嘉元, 李敏, 等. 核心指标集研究方案的标准报告条目解读及不同核心指标集研究报告指南对中医药领域研究的意义. 中国循证医学杂志, 2019, 19(12): 1492-1497.
|
8. |
李凯, 张俊华, 张明妍, 等. 中医药核心指标集(COS-TCM)研究现状. 世界科学技术-中医药现代化, 2021, 23(8): 2556-2562.
|
9. |
张俊华. 中医药核心指标集研究进展与展望. 中国药物评价, 2022, 39(2): 101-104.
|
10. |
邱瑞瑾, 魏旭煦, 关之玥, 等. 中医药领域核心指标集研究现状及展望. 中国循证医学杂志, 2023, 23(2): 211-220.
|
11. |
杨继, 张垚, 张运娇, 等. 基于主成分分析的中医药治疗慢性心力衰竭临床随机对照试验核心结局指标研究. 中西医结合心脑血管病杂志, 2021, 19(15): 2496-2509.
|
12. |
Li G, Han R, Lin M, et al. Developing a core outcome set for clinical trials of Chinese medicine for hyperlipidemia. Front Pharmacol, 2022, 13: 847101.
|
13. |
Niu B, Zhang M, Chua HZ, et al. Treatment of chronic pulmonary heart disease with traditional Chinese medicine: a protocol for the development of a core outcome set (COS-TCM-CPHD). Evid Based Complement Alternat Med, 2021, 2021: 5559883.
|
14. |
孙亚男. 基于系统评价与专家共识建立中医治疗乙肝的核心结局指标集: 方案. 世界中联伦理审查委员会第四届学术年会暨世界中联临床疗效评价专业委员会第八届学术年会论文集, 2014: 330-332.
|
15. |
Zhang T, Li X, Zhao L, et al. Development of a core outcome set in the clinical trials of traditional Chinese medicine for stroke: a study protocol. Front Med (Lausanne), 2022, 9: 753138.
|
16. |
Qiu R, Zhong C, Han S, et al. Development of a core outcome set for myocardial infarction in clinical trials of traditional Chinese medicine: a study protocol. BMJ Open, 2019, 9(12): e032256.
|
17. |
Zhang M, Chua HZ, Zhang J, et al. Developing a core outcome set on traditional Chinese medicine (COS-TCM) for chronic heart failure (CHF): a study protocol. BMJ Open, 2021, 11(7): e047148.
|
18. |
Jia M, Lu Y, Liang X, et al. Development of a core outcome set for hypertensive intracerebral hemorrhage in clinical trials of traditional Chinese medicine: a study protocol. Trials, 2022, 23(1): 871.
|
19. |
Qiu R, Li M, Zhang X, et al. Development of a core outcome set (COS) and selecting outcome measurement instruments (OMIs) for non-valvular atrial fibrillation in traditional Chinese medicine clinical trials: study protocol. Trials, 2018, 19(1): 541.
|
20. |
Li G, Zhou L, Ouyang W, et al. A core outcome set for clinical trials of Chinese medicine for hyperlipidemia: a study protocol for a systematic review and a Delphi survey. Trials, 2019, 20(1): 14.
|
21. |
Zhang MY, Zhang JH, Cai HZ, et al. Core outcome set for stable angina pectoris in traditional Chinese medicine (COS-SAP-TCM). Acupunct Herb Med, 2021, 1(1): 39-48.
|
22. |
孙亚男, 何丽云, 雒琳, 等. 中医药治疗慢性乙型肝炎临床试验的核心结局指标集研究. 中华中医药杂志, 2020, 35(9): 4684-4688.
|
23. |
邱瑞瑾. 中医临床研究核心指标集的方法构建. 北京: 北京中医药大学, 2018.
|
24. |
李心怡, 石兆峰, 胡嘉元, 等. 针刺治疗偏头痛核心结局指标集的建立. 世界科学技术-中医药现代化, 2020, 22(1): 7-12.
|
25. |
Xie Q, Deng X, Xiao J, et al. Protocol of the development of a core outcome set for ischemic stroke in clinical trials of chinese medicine. Evid Based Complement Alternat Med, 2020, 2020: 2649843.
|
26. |
谢倩文, 肖晶旻, 邓雪仪, 等. 建立中医药治疗缺血性卒中核心结局指标集的初步研究. 中医杂志, 2022, 63(3): 220-228.
|
27. |
万颖. 慢性腰痛中医临床研究核心结局指标集的构建. 北京: 北京中医药大学, 2021.
|
28. |
Liu M, Gao Y, Yuan Y, et al. Sjogren's syndrome in clinical trials of traditional Chinese medicine: protocol for the development of a core outcome set. Trials, 2021, 22(1): 233.
|
29. |
白杨, 宏亚丽, 陈波, 等. 针灸治疗粘连性肩关节囊炎临床研究核心结局指标集的构建方法. 中国针灸, 2023, 43(6): 701-705.
|
30. |
李凯. 中医药治疗肺癌核心指标集研究. 天津: 天津中医药大学, 2021.
|
31. |
秦懿囡, 徐天宇, 李泽鑫, 等. 初步构建针刺治疗特发性面神经麻痹核心结局指标集. 世界科学技术-中医药现代化, 2023, 25(3): 1069-1077.
|
32. |
Qiu R, Zhao C, Liang T, et al. Core outcome set for clinical trials of COVID-19 based on traditional Chinese and western medicine. Front Pharmacol, 2020, 11: 781.
|
33. |
Jin X, Pang B, Zhang J, et al. Core outcome set for clinical trials on coronavirus disease 2019 (COS-COVID). Engineering (Beijing), 2020, 6(10): 1147-1152.
|
34. |
Qiu R, Zhong C, Wan S, et al. Developing a core outcome set for assessing clinical safety outcomes of cardiovascular diseases in clinical trials of integrated traditional Chinese medicine and western medicine: study protocol. Trials, 2022, 23(1): 239.
|
35. |
Qiu R, Han S, Wei X, et al. Development of a core outcome set for the benefits and adverse events of acute heart failure in clinical trials of traditional Chinese medicine and western medicine: a study protocol. Front Med (Lausanne), 2021, 8: 677068.
|
36. |
Sheng X, Chen C, Ji Z, et al. Development of a core outcome set on traditional Chinese medicine and western medicine for rheumatic heart disease: a study protocol. BMJ Open, 2022, 12(11): e062497.
|
37. |
嵇鑫陈. 中医药治疗重症肌无力的临床研究核心指标集构建研究. 长春: 长春中医药大学, 2022.
|
38. |
张明妍, 张俊华, 杜亮, 等. 核心指标集研制规范(COS-STAD)介绍及其在中医药领域应用的思考. 中国循证医学杂志, 2018, 18(4): 392-396.
|
39. |
张明妍, 杨丰文, 李越, 等. 核心指标集报告规范(COS-STAR)介绍. 中国循证医学杂志, 2017, 17(7): 857-861.
|
40. |
蔡慧姿, 张明妍, 李凯, 等. 核心指标集标准方案(COS-STAP)解读及在中医药领域应用的思考. 世界科学技术-中医药现代化, 2021, 23(8): 2580-2586.
|
41. |
张明妍, 牛柏寒, 蔡慧姿, 等. 中医药核心指标集研究利益相关群体选择实施要点. 世界科学技术-中医药现代化, 2021, 23(8): 2563-2568.
|
42. |
张明妍, 牛柏寒, 蔡慧姿, 等. 中医药核心指标集(COS-TCM)Delphi实施要点. 世界科学技术-中医药现代化, 2021, 23(8): 2569-2575.
|
43. |
牛柏寒, 张明妍, 蔡慧姿, 等. 中医药核心指标集研究中共识方法实施要点. 世界科学技术-中医药现代化, 2021, 23(8): 2576-2579.
|
44. |
张明妍, 蔡慧姿, 牛柏寒, 等. 中医药核心指标集研究中指标池构建相关影响因素分析. 中国循证医学杂志, 2021, 21(4): 464-468.
|
45. |
张冬, 张明妍, 郑文科, 等. 中医药临床试验核心指标集构建及德尔菲法实施规范. 中医杂志, 2017, 58(1): 20-22.
|
46. |
张明妍, 张俊华, 张伯礼, 等. 中医药临床试验核心指标集研制技术规范. 中华中医药杂志, 2021, 36(2): 924-928.
|
47. |
张俊华, 王海南. 临床评价核心指标集研究方法与实践. 上海: 上海科学技术出版社, 2021: 63.
|
48. |
Liu M, Gao Y, Yuan Y, et al. Inconsistency and low transparency were found between core outcome set protocol and full text publication: a comparative study. J Clin Epidemiol, 2021, 131: 59-69.
|